Table 1.
Conditions | 0.2% LH | IL-1β | PDGF-BB | 20% FCS |
---|---|---|---|---|
Hyaluronan* | 5 ± 1 | 65 ± 24§ | 129 ± 11§ | 161 ± 18§ |
CSPG† | 19 ± 5 | 45 ± 6‡ | 123 ± 37§ | 167 ± 48§ |
DSPG† | 351 ± 74 | 416 ± 138 | 807 ± 242‡ | 675 ± 178‡ |
HSPG† | 167 ± 45 | 215 ± 31 | 239 ± 36 | 255 ± 76 |
Cell numbers (×10−3) | 41 ± 4 | 43 ± 15 | 66 ± 17 | 65 ± 6 |
Cells were metabolically labeled with [35S]-sulfate or [3H]-glucosamine and incubated with the agents shown for 36 hours, as described in Materials and Methods. The conditioned medium and cell extracts were then prepared and specific activity counted as described.
[3H]-glucosamine dpm/103 cells ± 1 SD (n = 3).
[35S]-sulfate dpm/103 cells ± 1 SD (n = 3).
Statistical difference to control levels is shown as
P < 0.05 and
P < 0.01.